India drugmakers seek tax relief, faster dispute resolution ahead of Budget 2026
Arti Bali New Delhi, Jan 29 (UNI) India’s pharmaceutical industry has urged the government to implement sweeping direct tax reforms in the union Budget 2026-27, emphasising the need for stronger incentives for research and development (R&D), domestic API manufacturing, and simplified compliance to improve the ease of doing business. With Finance Minister Nirmala Sitharaman set…
